(RYTM) Rhythm Pharmaceuticals - Performance 54% in 12m
Compare RYTM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
67.03%
#8 in Group
Rel. Strength
90.61%
#750 in Universe
Total Return 12m
53.99%
#28 in Group
Total Return 5y
235.44%
#8 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -3.17%
20th Percentile in Group
12m Total Return: RYTM (54%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: RYTM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RYTM
Total Return (including Dividends) | RYTM | XBI | S&P 500 |
---|---|---|---|
1 Month | 27.60% | 5.55% | -0.45% |
3 Months | 7.39% | -9.75% | -6.29% |
12 Months | 53.99% | -5.39% | 13.04% |
5 Years | 235.44% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | RYTM | XBI | S&P 500 |
1 Month | 89.1% | 70% | 47.5% |
3 Months | 26.4% | -88.1% | -87.3% |
12 Months | 80.1% | -44.4% | 54.3% |
5 Years | 62.4% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #32 | 20.9% | 28.2% |
3 Month | #36 | 19.0% | 14.6% |
12 Month | #28 | 62.8% | 36.2% |
5 Years | #10 | 286% | 58.4% |
FAQs
Does RYTM Rhythm Pharmaceuticals outperforms the market?
Yes,
over the last 12 months RYTM made 53.99%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months RYTM made 7.39%, while XBI made -9.75%.
Over the last 3 months RYTM made 7.39%, while XBI made -9.75%.
Performance Comparison RYTM vs Indeces and Sectors
RYTM vs. Indices RYTM is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.83% | 28.1% | 31.8% | 41.0% |
US NASDAQ 100 | QQQ | -1.75% | 25.7% | 31.1% | 39.0% |
US Dow Jones Industrial 30 | DIA | -0.29% | 30.5% | 32.5% | 44.7% |
German DAX 40 | DAX | -0.47% | 27.8% | 13.7% | 29.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.82% | 30.8% | 35.5% | 49.0% |
Hongkong Hang Seng | HSI | -0.43% | 29.1% | 31.2% | 41.1% |
India NIFTY 50 | INDA | 1.69% | 22.7% | 31.9% | 51.1% |
Brasil Bovespa | EWZ | 0.80% | 24.8% | 26.1% | 60.7% |
RYTM vs. Sectors RYTM is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.98% | 28.2% | 25.8% | 30.5% |
Consumer Discretionary | XLY | -0.86% | 28.2% | 30.6% | 39.3% |
Consumer Staples | XLP | 1.23% | 28.4% | 27.7% | 43.1% |
Energy | XLE | 3.43% | 41.6% | 36.9% | 63.3% |
Financial | XLF | 0.28% | 29.6% | 24.8% | 31.3% |
Health Care | XLV | 1.87% | 32.3% | 36.9% | 55.2% |
Industrial | XLI | -1.15% | 27.3% | 30.7% | 43.3% |
Materials | XLB | 0.98% | 30.8% | 39.6% | 58.4% |
Real Estate | XLRE | -0.72% | 28.7% | 31.6% | 35.6% |
Technology | XLK | -2.39% | 25.2% | 34.7% | 43.6% |
Utilities | XLU | 0.45% | 27.5% | 27.3% | 33.2% |
Aerospace & Defense | XAR | -1.86% | 20.6% | 17.9% | 26.5% |
Biotech | XBI | -0.67% | 22.1% | 47.1% | 59.4% |
Homebuilder | XHB | 0.44% | 29.7% | 46.7% | 60.2% |
Retail | XRT | 0.41% | 28.8% | 37.7% | 55.5% |